Smith & Nephew (SNN) Cash from Investing Activities (2009 - 2024)
Smith & Nephew (SNN) reported Cash from Investing Activities of -$360.0 million for Q4 2024, down 97.8% on a YoY basis from -$16.4 billion in Q1 2024, and down 97.8% quarter-over-quarter from -$182.0 million in Q4 2023.
Smith & Nephew (SNN) Cash from Investing Activities (2009 - 2024) Analysis & Trends
Smith & Nephew has reported Cash from Investing Activities for 16 years, with the latest figure at -$360.0 million in Q4 2024.
- For the quarter ending Q4 2024, Cash from Investing Activities fell 97.8% year-over-year to -$360.0 million; the trailing twelve-month figure through Dec 2024 stood at -$1.2 billion (down 2.82% YoY), and the FY2025 full-year result was -$406.0 million, up 28.65% from the prior year.
- Cash from Investing Activities for Q4 2024 stood at -$360.0 million, down from -$182.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$182.0 million in Q4 2023, with the low at -$431.0 million in Q4 2021.
- Historically, Cash from Investing Activities has averaged -$313.4 million across 5 years, with a median of -$326.0 million in 2020.
- Annual changes were most pronounced in 2020 — Cash from Investing Activities surged 73.94% — and 2024, when it sank 97.8%.
- Smith & Nephew's Cash from Investing Activities stood at -$326.0 million in 2020, then sank by 32.21% to -$431.0 million in 2021, then surged by 37.82% to -$268.0 million in 2022, then jumped by 32.09% to -$182.0 million in 2023, then slumped by 97.8% to -$360.0 million in 2024.
- The last three Cash from Investing Activities figures came in at -$360.0 million (Q4 2024), -$182.0 million (Q4 2023), and -$268.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Smith & Nephew | 5.34 Bn | 4.77 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -360.00 Mn |
| Dec 31, 2024 | -360.00 Mn |
| Dec 31, 2023 | -182.00 Mn |
| Dec 31, 2023 | -182.00 Mn |
| Dec 31, 2022 | -268.00 Mn |
| Dec 31, 2022 | -268.00 Mn |
| Dec 31, 2021 | -431.00 Mn |
| Dec 31, 2021 | -431.00 Mn |
| Dec 31, 2020 | -326.00 Mn |
| Dec 31, 2020 | -326.00 Mn |
| Dec 31, 2019 | -1.25 Bn |
| Dec 31, 2019 | -1.25 Bn |
| Dec 31, 2018 | -378.00 Mn |
| Dec 31, 2018 | -378.00 Mn |
| Dec 31, 2017 | -543.00 Mn |
| Dec 31, 2017 | -543.00 Mn |
| Dec 31, 2016 | -383.00 Mn |
| Dec 31, 2016 | -383.00 Mn |
| Dec 31, 2015 | -429.00 Mn |
| Dec 31, 2015 | -429.00 Mn |